CAEX SA
The score of CAEX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +11807 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →CAEX's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −35,823 € | ||||
| Equity | −882,245 € | ||||
| Cash | 296 € | ||||
| EBITDA | −3,320 € | ||||
| Total assets | 270,481 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
CAEX's financial analysis
- Solvency-326.2%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CAEX
CAEX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.783.141
- VAT number
- BE0451783141
- Peppol
- Registered · 0208:0451783141 · as of 30 Oct 2026
- Legal form
- SA
- Incorporated
- 28 Jan 1994
- Registered office
- 2580 Putte
- Latest accounts
- 2025 · filed on 25 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
CAEX (SA) has been based in Putte since 1994, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 35,823 € and equity of −882,245 €; its revenue is not published. Its solvency stands at -326.2%, below the median of its sector (46.0%).
Companies similar to CAEX
Companies in the same business, of comparable size and area, outside its group.
- Allmedics Wholesale of pharmaceutical and medical goods Keerbergen · balance sheet 281,788 €
- GUANG JI Pharmaceutical Belgium sa Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 32,994 €
- DE Dommel Business and other management consultancy activities Waasmunster · balance sheet 730,988 €
- Vetwise Business and other management consultancy activities Sint-Niklaas · balance sheet 62,537 €
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Vervloet MSM Wholesale of pharmaceutical and medical goods Sint-Niklaas · balance sheet 189,219 €
- Meda Bright Wholesale of pharmaceutical and medical goods Brussels · balance sheet 469,972 €
Frequently asked questions about CAEX
What is the revenue of CAEX?
CAEX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CAEX?
In Belgium, the VAT number is the company number prefixed with BE: BE0451783141 for CAEX, if the company is VAT-registered. Its company number (CBE) is 0451.783.141.
Where is the registered office of CAEX?
According to the CBE register, the registered office of CAEX is in 2580 Putte.
What is the equity of CAEX?
At the close of the 2025 financial year, the equity of CAEX amounts to -882,245 €, a solvency of -326.2% of total assets.
Who manages CAEX?
The register lists 4 active mandates at CAEX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CAEX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →